Novogene Co Ltd Class A 688315
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥9.86
- Day Range
- ¥9.78–10.05
- 52-Week Range
- ¥9.63–27.43
- Bid/Ask
- ¥9.88 / ¥9.89
- Market Cap
- ¥4.12 Bil
- Volume/Avg
- 1.7 Mil / 2.9 Mil
Key Statistics
- Price/Earnings (Normalized)
- 30.05
- Price/Sales
- 1.99
- Dividend Yield (Trailing)
- 0.48%
- Dividend Yield (Forward)
- 0.48%
- Total Yield
- 0.48%
Company Profile
Novogene Co Ltd is engaged in providing multi-level scientific research and technical services and solutions for life science basic research, medical and clinical application research, and independent development and innovation of genetic testing medical equipment.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 2,144
- Website
- https://en.novogene.com
Comparables
Valuation
|
Metric
|
688315
|
688217
|
688179
|
|---|---|---|---|
Price/Earnings (Normalized) | 30.05 | 437.73 | 25.82 |
Price/Book Value | 1.69 | 0.79 | 2.49 |
Price/Sales | 1.99 | 2.67 | 5.70 |
Price/Cash Flow | 16.09 | 35.45 | 25.69 |
Price/Earnings
688315
688217
688179
Financial Strength
|
Metric
|
688315
|
688217
|
688179
|
|---|---|---|---|
Quick Ratio | 1.86 | 9.90 | 7.60 |
Current Ratio | 2.40 | 11.86 | 13.18 |
Interest Coverage | 109.58 | — | — |
Quick Ratio
688315
688217
688179
Profitability
|
Metric
|
688315
|
688217
|
688179
|
|---|---|---|---|
Return on Assets (Normalized) | 4.34% | 0.15% | 5.58% |
Return on Equity (Normalized) | 6.43% | 0.17% | 8.18% |
Return on Invested Capital (Normalized) | 6.12% | 0.16% | 6.07% |
Return on Assets
688315
688217
688179
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk A/S ADR
NVO
| Ghgmzcfwsd | Wmncj | $565.6 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Jxcbsdb | Dcmgdb | $127.8 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Sjtyhtksb | Bqcmwlk | $118.7 Bil | |||
| Moderna Inc
MRNA
| Fxrlncbg | Ppzn | $46.8 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Flxnwpms | Jgjymn | $29.7 Bil | |||
| argenx SE ADR
ARGX
| Nkjprytk | Pzl | $29.3 Bil | |||
| BioNTech SE ADR
BNTX
| Brkfwrx | Szmvj | $20.7 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Rqfjmffwc | Yljhsjf | $16.1 Bil | |||
| United Therapeutics Corp
UTHR
| Cdnxcktwl | Zlf | $15.0 Bil | |||
| Incyte Corp
INCY
| Dpkmcbdbj | Fbhccj | $13.5 Bil |